SA- cardiac dz Flashcards
what are the main4 effects of CHF
- inc HR/arrhythmia
- oedema and effusions
- remodelling and fibrosis
- vasoconstriction
what 2 things try to counter RAAS
- ANP
- BNP
they are released due to chamber stretch and try to vasodil and diuresis
this can be used to dx
what factors cause vasoconstriction in CHF
ANG II
endothelin
NA at a2-R
ADH
due to bradykinin being decreased from the action of ACE, what other vasodilating factors are blocked
PG
NO
what is the action of ANG II
- decreased bradykinin
- inc aldosterone
- remodelling/fibrosis
- ADH release
- endothelin release
- stem release of NA
- constriction of off arteriole = inc GFR
what is the purpose of ACE inhib
to counter the effects of ANGII
what is the purpose of ANGII-r blockers (mainly human atm)
used to avoid ACE-Inhib SE in humans, but means bradykinin doesn’t increase. ALSO ANGII made by chymases too not just ACE
ACE inhibit don’t always block enough aldosterone, so how do you do that?
sprinolactone - k sparing too
what is the ‘la place’ relationship? (related to hypertrophy)
wall stress = radius x pressure / 2x wall thickness
what ar the 2 forms of hypertrophy
- eccentric (wider lumen)
- concentric (thicker wall)
what is a path result of vol overload
mitral regurg
how does physiological compensatory hypertrophy become pathological
if dilation is more than hypertrophy can compensate for –> myocardial cells ‘slip’ and heart fails
do myocytes get fatter or longer in eccentric and concentric hypertrophy
concentric = fatter, p overload eccentric = longer,, vol overload
what is the 1st problem of CHF that needs addressing wrt tx
the Na and water retention
LHS - pull oedema; HS = ascite, pleural effusion and hepatomegaly
how do you dress the na and water retention ?
diuretics
- 1st choice = furosemide
what is the aim of diuretic tx
lowest poss dose
start bid/tid –> sid
train O to take resting RR and then can lower dose until RR increases
what are the SE of furosemide that need to be monitored?
pre-renal azotaemia= U;Cr
hypokalaemia
short-term use only of RAAS+
what might the effect of GI oedema be re drugs/furosemide
can’t be absorbed
name a more potent 2nd choice diuretic
loop-diuretic torasemide
describe the principles of a sequential nephron blockade
using diuretics acting on diff parts on the renal tubules
what is indicated in pleural effusion
thoracocentessi
what must you ascertain before beginning treatment of RHS CHF ?
whether due to pericardial effusion first
what type of drugs are all the ACE inhib
pro-drugs
ACE-I are almost always indicated in cases of CHF, however when should they not be given and why
in cases of severe hypotension, where furosemide is given in high doses OR if there is aortic stenosis
what are the SE of ACE-I
hypotension
renal impairment
hyperkalaemia
anorexia, d+. v+
how can pulmonary oedema be treated initially
with vasodilation
- use furosemide IV
- topical nitroglycerine (percutol) or as a patch
why would arteriodilators be useful>
to reduce systemic p, wo reducing perfusion. unloads failing heart
name some arteriodil drugs
pimobendan
amlodipine
hydrazine
ACE-I
how does pimobendan work (vetmedin)
Ca++ sensitiser - so contractility increases wo any more Ca++
also inhibits PDE therefore = vasodil and +ve inotrope
why is it good that pimobendan doest inc intracellular Ca++
as it induces arrhythmias (makes it better than other PDE-I)
high sympathetic drive is the reason for tachycardia - how can this be reduced
- indirectly!
b-blocker r blockade
(digoxin)
why would b-blockers be VERY CI in the CHF patients
if not controlled - as sympathetic drive is crucial to maintaining the heart ! wo it, it will arrest - so get other bits sorted before you add bblockers
what is the effects of digoxin (B-blocker)
inc vagal tone - @ low end of dose rate
- direct stem of vagal centre in CNS
- sensitises baro-R
- inc cardiac pacemaker response to ACh
neg chronotrope, pos inotrope
digoxin is toxic and with a narrow therapeutic index - what signs do you need to look for>
- XS borborygmi
- depression
- anorexia
- V+D
- arrhythmias